Replies to post #220389 on Avid Bioservices Inc (CDMO)

[DewDiligence]

Enrollment behind schedule announcement won't happen because Mgt can and will change the definition which they control and we have never known what it means anyway.

It would be a simple matter for management to give the approximate number of patients enrolled to date, but they won’t do it, and that is a bright red flag.

Compare PPHM’s statements vis-à-vis SUNRISE enrollment with the way OCRX (a small biotech pursuing liver disease) talks about enrollment in the phase-3 ‘STOP-HE’ study (http://seekingalpha.com/article/3133496-ocera-therapeutics-ocrx-ceo-linda-grais-on-q1-2015-results-earnings-call-transcript?part=single ):

…I'm delighted to say that we've seen a consistent increase in enrollment since the beginning or the year. We now have a total of approximately 90 sites active in the U.S., Europe, Russia and Israel, and as of today we've enrolled over 70 patients, roughly one-third of our enrollment target.

…since the beginning of the year we have enrolled over 40 patients; at this enrollment rate of 10 patients per month we expect to complete enrollment in the second half of 2016.

Emphasis added.